Drug profile

The FDA adverse-event record for Lasalocid Sodium

254 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Lasalocid Sodium. See the species affected, top reactions, and outcomes below.

254
adverse-event reports
48.0%
death-coded share
Cattle
most-reported species
82
Death - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
254
Total Reports
122
Deaths Reported
48.0%
Death Rate

Active Ingredients

Lasalocid Sodium

Administration Routes

OralUnknownTopical

Species Affected

Cattle 176
Unknown 20
Horse 12
Turkey 10
Chicken 9
Sheep 7
Dog 5
Pig 3
Other Birds 3
Goat 2

Most Affected Breeds

Cattle (other) 81
Mixed (Cattle) 42
Holstein-Friesian also known as Holstein 33
Unknown 31
Jersey 10
Horse (unknown) 8
Sheep (unknown) 7
Turkey (unknown) 6
Aberdeen Angus 4
Chicken (other) 4

Most Reported Reactions

Death 82
Lack of efficacy (protozoa) - Coccidia 50
INEFFECTIVE, COCCIDIA 41
Lack of efficacy - NOS 39
Sudden death 13
Underdose 11
Unexplained death 11
No sign 10
Ruminal bloat 9
Diarrhoea 8
Overdose 7
Death by euthanasia 6

Outcome Breakdown

Outcome Unknown
134 (44.1%)
Died
119 (39.1%)
Recovered/Normal
30 (9.9%)
Ongoing
13 (4.3%)
Euthanized
7 (2.3%)
Recovered with Sequela
1 (0.3%)

Lasalocid Sodium Adverse Event Insights

254 reports name Lasalocid Sodium; 122 recorded a death outcome (48.0% of reported events, not a population-level mortality rate). Active ingredient: Lasalocid Sodium. Administration routes: Oral, Unknown, Topical.

By species: Cattle (176 reports), Unknown (20 reports), Horse (12 reports). By breed: Cattle (other) (81), Mixed (Cattle) (42), Holstein-Friesian also known as Holstein (33).

Leading clinical signs: Death (82), Lack of efficacy (protozoa) - Coccidia (50), INEFFECTIVE, COCCIDIA (41), Lack of efficacy - NOS (39). Outcome, 304 coded reports: Outcome Unknown leads at 44.1%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.